X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (43) 43
female (31) 31
adult (27) 27
male (24) 24
oncology (23) 23
middle aged (22) 22
index medicus (19) 19
aged (17) 17
chemotherapy (14) 14
cancer (12) 12
human necessities (11) 11
hygiene (11) 11
medical or veterinary science (11) 11
preparations for medical, dental, or toilet purposes (11) 11
chemistry (10) 10
metallurgy (10) 10
organic chemistry (10) 10
peptides (10) 10
medicine & public health (9) 9
adolescent (8) 8
breast cancer (8) 8
retrospective studies (8) 8
treatment outcome (8) 8
carcinoma (7) 7
care and treatment (7) 7
hematology (7) 7
medicine, general & internal (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
beer (6) 6
biochemistry (6) 6
breast neoplasms - pathology (6) 6
child (6) 6
compositions or test papers therefor (6) 6
condition-responsive control in microbiological orenzymological processes (6) 6
enzymology (6) 6
measuring or testing processes involving enzymes, nucleicacids or microorganisms (6) 6
microbiology (6) 6
mutation or genetic engineering (6) 6
processes of preparing such compositions (6) 6
rheumatology (6) 6
specific therapeutic activity of chemical compounds ormedicinal preparations (6) 6
spirits (6) 6
vinegar (6) 6
wine (6) 6
cells (5) 5
docetaxel (5) 5
dose-response relationship, drug (5) 5
drug resistance (5) 5
familial mediterranean fever (5) 5
gastroenterology & hepatology (5) 5
investigating or analysing materials by determining theirchemical or physical properties (5) 5
measuring (5) 5
metastasis (5) 5
paclitaxel (5) 5
pharmacology & pharmacy (5) 5
physics (5) 5
quality of life (5) 5
survival (5) 5
testing (5) 5
acute lymphoblastic-leukemia (4) 4
aged, 80 and over (4) 4
analysis (4) 4
antineoplastic agents - adverse effects (4) 4
apoptosis (4) 4
child, preschool (4) 4
disease-free survival (4) 4
expression (4) 4
genetic aspects (4) 4
lung neoplasms - drug therapy (4) 4
mcf-7 (4) 4
methotrexate (4) 4
methotrexate - metabolism (4) 4
resistance (4) 4
respiratory system (4) 4
risk factors (4) 4
survival rate (4) 4
therapy (4) 4
tumor cells, cultured (4) 4
usage (4) 4
adenocarcinoma (3) 3
antineoplastic agents - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
association (3) 3
breast neoplasms - drug therapy (3) 3
cell line, tumor (3) 3
college teachers (3) 3
drug administration schedule (3) 3
enzyme-linked immunosorbent assay (3) 3
erlotinib (3) 3
fatal outcome (3) 3
fluorouracil - administration & dosage (3) 3
further section (3) 3
gemcitabine (3) 3
growth-factor receptor (3) 3
irinotecan (3) 3
lung cancer (3) 3
medical colleges (3) 3
multicenter (3) 3
mutation (3) 3
neoplasm metastasis (3) 3
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (96) 96
Turkish (11) 11
French (4) 4
Korean (2) 2
Chinese (1) 1
German (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 897 - 907
Journal Article
by Mok, Tony and Mok, Tony S K and Wu, Yilong and Wu, Yi-Long and Kudaba, Iveta and Kowalski, Dariusz M and Kowalski, Dariusz and Cho, Byoung Chul and Turna, Hande and Turna, Hande Z and Castro, Hugo and Castro, Gilberto and Srimuninnimit, Vichien and Laktionov, Konstantin and Laktionov, Konstantin K and Bondarenko, Igor and Kubota, Kaoru and Lubiniecki, Gregory M and Zhang, Jin and Zhang, Li and Zhang, Xin and Kush, Debra and Lopes, Valeria and Lopes, Gilberto and Adamchuk, Grigory and Ahn, Myung-Ju and Alexandru, Aurelia and Altundag, Ozden and Alyasova, Anna and Andrusenko, Orest and Aoe, Keisuke and Araujo, Antonio and Aren, Osvaldo and Arrieta Rodriguez, Oscar and Ativitavas, Touch and Avendano, Oscar and Barata, Fernando and Barrios, Carlos Henrique and Beato, Carlos and Bergstrom, Per and Betticher, Daniel and Bolotina, Larisa and Botha, Michiel and Buddu, Sayeuri and Caglevic, Christian and Cardona, Andres and Cay Senler, Filiz and Cerny, Carlos Alexandre Sydow and Cesas, Alvydas and Chan, Gee-Chen and Chang, Jianhua and Chen, Xi and Chen, Gongyan and Cheng, Ying and Cheng, Susanna and Cherciu, Nelly and Chiu, Chao-Hua and Cicenas, Saulius and Ciurescu, Daniel and Cohen, Graham and Costa, Marcos Andre and Danchaivijitr, Pongwut and De Angelis, Flavia and de Azevedo, Sergio Jobim and Dediu, Mircea and Deliverski, Tsvetan and De Marchi, Pedro Rafael Martins and de The Bustamante Valles, Flor and Ding, Zhenyu and Doganov, Boyan and Dreosti, Lydia and Duarte, Ricardo and Edusma-Dy, Regina and Emelyanov, Sergey and Erman, Mustafa and Fan, Yun and Fein, Luis and Feng, Jifeng and Fenton, David and Fernandes, Gustavo and Ferreira, Carlos and Franke, Fabio Andre and Freitas, Helano and Fujisaka, Yasuhito and Galindo, Hector and Galvez, Christina and Ganea, Doina and Gil, Nuno and Girotto, Gustavo and Goker, Erdem and Goksel, Tuncay and Gomez Aubin, Gonzalo and Gomez Wolff, Luis and Griph, Hakan and Gumus, Mahmut and Hall, Jacqueline and Hart, Gregory and Havel, Libor and He, Yong and He, Jianxing and ... and KEYNOTE-042 Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10183, pp. 1819 - 1830
First-line pembrolizumab monotherapy improves overall and progression-free survival in patients with untreated metastatic non-small-cell lung cancer with a... 
MEDICINE, GENERAL & INTERNAL | CARBOPLATIN | GEFITINIB | BEVACIZUMAB | CRIZOTINIB | NIVOLUMAB | PACLITAXEL | Genes, erbB-1 - drug effects | Lung Neoplasms - drug therapy | Translocation, Genetic | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Lung Neoplasms - metabolism | Middle Aged | Far East - epidemiology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Anaplastic Lymphoma Kinase - genetics | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Lung Neoplasms - secondary | Female | Carcinoma, Non-Small-Cell Lung - pathology | Anaplastic Lymphoma Kinase - drug effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Genes, erbB-1 - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Disease-Free Survival | B7-H1 Antigen - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm Metastasis - pathology | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Chemotherapy | Metastasis | Lung cancer, Non-small cell | Cancer | Slopes | Lung cancer | Oncology | Kinases | Cancer therapies | Metastases | Pembrolizumab | Randomization | Motivation | Platinum | Risk assessment | Population | Translocation | Cell survival | Life expectancy | Epidermal growth factor receptors | Hyperthyroidism | Histology | Hypothyroidism | Survival | Patients | Medical centres | Life span | Interactive systems | PD-L1 protein | Men | Ligands | Tumors | Apoptosis
Journal Article
Journal Article
Computers in Biology and Medicine, ISSN 0010-4825, 2013, Volume 43, Issue 12, pp. 2103 - 2109
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 11/2019, Volume 41, Issue 11, pp. 2382 - 2396
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 4/2015, Volume 20, Issue 2, pp. 395 - 404
Journal Article
by Tunca, Mehmet and Ozdogan, Huri and Kasapcopur, Ozgur and Yalcinkaya, Fatos and Tutar, Ercan and Topaloglu, Rezan and Yilmaz, Engin and Arici, Mustafa and Bakkaloglu, Aysin and Besbas, Nesrin and Akpolat, Tekin and Dinc, Ayhan and Erken, Eren and Tirpan, Kazim and Ozer, Huseyin TE and Soyturk, Mujde and Senturk, Taskin and Balci, Banu and Ozguc, Meral and Dundar, Munis and Akar, Ece and Ozel, Duygu and Dundar, Munis and Gunesacar, Ramazan and Booth, David R and Hawkins, Philip N and Touitou, Isabelle and Aksentijevich, Ivona and Matzner, Yakov and Arslan, Serap and Balaban, Yasemin and Batman, Figen and Bayraktar, Yusuf and Apras, Sule and Calguneri, Meral and Duzova, Ali and Kav, Taylan and Ozaltin, Fatih and Simsek, Halis and Sivri, Bulent and Tatar, Gonca and Akkoc, Nurullah and Kavukcu, Salih and Soylu, Alper and Turkmen, Mehmet and Unsal, Erbil and Arisoy, Nil and Caliskan, Salim and Gogus, Feride and Masatlioglu, Seval and Sever, Lale and Akkok, Nermin and Cakar, Nilgun and Kara, Nazli and Kocak, Hulusi and Ozalp, Sila and Bilge, Ilmay and Sevinc, Emre and Gul, Ahmet and Kamali, Sevil and Sadikoglu, Banu and Selcukbiricik, Fatih and Sirin, Aydan and Sucu, Aysegul and Bek, Kenan and Bulbul, Mehmet and Delibas, Ali and Demircin, Gulay and Erdogan, Ozlem and Oner, Ayse and Mesiha, Ekim and Ozkaya, Nuray and Tekin, Mustafa and Demirkaya, Erkan and Erdem, Hakan and Gok, Faysal and Pay, Salih and Islek, Ismail and Kabasakal, Yasemin and Keser, Gokhan and Ozmen, Mustafa and Akoglu, Emel and Atagunduz, Pamir and Direskeneli, Haner and Temel, Musa and Tuglular, Serhan and Buyan, Necla and Bakkaloglu, Sevcan and Derici, Ulver and Goker, Berna and Kalman, Suleyman and Ozkaya, Ozan and Dusunsel, Ruhan and Gunduz, Zubeyde and Poyrazoglu, M. Hakan and Korkmaz, Cengiz and Baskin, Esra and Koseoglu, Hamide Kart and Saatci, Umit and Yucel, Eftal and ... and Turkish FMF Study Grp and Turkish FMF Study Group
Medicine, ISSN 0025-7974, 01/2005, Volume 84, Issue 1, pp. 1 - 11
Journal Article
Journal Article
Quality of Life Research, ISSN 0962-9343, 9/2009, Volume 18, Issue 7, pp. 853 - 861
Journal Article